21.03.2019 The robotic platform for extracting and screening antibiotic activities from bacterial strains is now operational for the analysis of several hundred strains monthly; Bpifrance paid €1.5m to DEINOVE as part of the first milestone payment of the AGIR Programme. DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to […]
The post DEINOVE passes the first milestone of the AGIR program and receives €1.5m from Bpifrance appeared first on SynBioBeta.